Continuous technological innovations coupled with high investments in healthcare are two key factors that fuel the global Artificial Organ and Bionics Market. Artificial organs refer to devices that are developed to replace natural organs in the human body. The need for organ transplant arises when a certain natural organ has either stopped working or doesn’t function properly. Artificial organs and artificial body parts are made from substances known as biomaterials.
Man made hazards and high frequency of accidents may propel the global artificial organ and bionics market during the forecast period (2014 to 2020). Artificial liver, artificial limbs, artificial pancreas, artificial heart, and artificial kidneys are examples of artificial organs that function exactly like natural organs when implanted in the human body. The application of electronics & mechanics in the field of medicine has led to newer innovations in developing artificial organs. The worldwide artificial organ and bionics market is categorized on the basis of products, technologies, and regions. Based on products, the segments are artificial pancreas, artificial liver, artificial lungs, artificial heart, and artificial kidney. Medical bionics products are further subdivided into cardiac bionics, brain bionics, vision bionics, heart bionics, limb bionics, and exoskeleton bionics. Due to high prevalence of heart disorders worldwide, the segment for heart bionics holds the largest share in the overall market. The artificial lungs & kidney segments held considerable industry shares in 2013. These segments may grow substantially during the forecast period because of problems, such as alcohol abuse and consumption of drugs & cigarettes. Browse Details of Report @ https://www.hexaresearch.com/research-report/artificial-organs-and-bionics-industry On the basis of technologies, the industry is bifurcated into mechanical bionics and electronic bionics. Rapid technological advancements have led to the development of medical bionics that meets the challenges of organ failure. Mechanical bionics is mostly employed in the development of orthopedic body parts. As per regions, the global artificial organ and bionics market is categorized into Europe, Asia Pacific, North America, and Rest of the World. North America led the industry in 2013. Factors that fuel this region are high investments in research & development and technological advancements. Growing geriatric population, rising cases of organ failure, and high incidence of accidents may contribute to regional growth over the forecast period. However, the Asia Pacific market is poised to grow rapidly over the next couple of years. This industry is driven by steady government support, medical tourism, and surging disposable incomes. Government support has led to improvements in healthcare infrastructures. Companies in the worldwide artificial organ and bionics market are Second Sight Medical Product Inc.; Medtronic Co. Ltd.; World Heart Corporation; Thoratec Corporation; and Lifenet Health. Besides being monopolistic, the global market is a highly competitive one too. Researchers have begun examining using 3D printing in the development of artificial organs. Organovo, a U.S. based biotech startup, focuses on 3D printing of human tissues. These are then sculpted in layers to form organs. Nano Dimension, an Israeli 3D printing company in collaboration with Accellta has successfully mixed human stem cells in printing inks. Accellta is an Israel based stem cell technology company. The striking feature of the inkjet methods of Nano Dimension is the speed at which it prints the human tissues. While most 3D printing techniques take hours to perform this task, Nano Dimension’s technology does it in a matter of seconds. Browse Related Category Reports @ https://www.hexaresearch.com/research-category/healthcare-it-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/
0 Comments
The worldwide Biopsy Devices Market is expected to grow at a nearly 6.5% CAGR over the forecast period (2012 to 2020). By 2020, the industry may report revenues worth almost USD 2.4 billion. High prevalence of infectious diseases and serious illnesses like cancer and kidney diseases can propel demand in the years to come. The removal of body tissues to rule out the growth of abnormal cells is known as biopsy. Biopsies are conducted quite frequently these days because of high incidence of deadly diseases.
Growing geriatric population is a prominent factor that may fuel the industry in the years to come. Different types of biopsies in cancer diagnosis are incision, skin, excision, and shave. Popularity of minimally invasive biopsy procedures can further contribute to global demand. The biopsy devices industry is gradually expanding in most emerging nations because of greater awareness, high incomes, investment in R&D, and high healthcare expenditure. Browse Details of Report @ https://www.hexaresearch.com/research-report/biopsy-devices-industry Products and regions are two parameters based on which the global Biopsy Devices Market is categorized. According to products, the industry is divided into biopsy forceps, biopsy guidance system, needle-based biopsy guns, biopsy needles, and others. “Others” refers to biopsy punches, curettes, and brushes. Guidance systems held the highest share in 2013 owing to high prices of robotic guidance systems. Popularity of accurate & minimally invasive devices and high incidence of cancer are two key factors that drive this segment. It is influenced by technological advancements and the surging demand for user-friendly products. Needle-based biopsy guns is a highly profitable segment because of surging demand for the same for obtaining soft tissue samples from bone marrows, kidneys, prostate glands, lungs, and breasts. Needle-based biopsy guns are further segmented into core needle, fine needle aspiration, and vacuum assisted biopsy devices. Biopsy forceps are of two types, namely hot and cold. The cold biopsy forceps segment can expand considerably in the years to come because these help prevent the onset of infectious diseases. The market for robotic guidance systems is projected to expand remarkably over the forecast period because of surging disposable incomes and substantial investments in technology. Geographically, the global Biopsy Devices Market is classified into Europe, Asia Pacific, North America, and Rest of the World. North America held maximum shares in 2013 in terms of revenue. The region may continue dominating the overall industry throughout the forecast period because of rising prevalence of cancer and greater awareness about biopsy devices. The Asia Pacific market may grow rapidly because of a booming population and an expanding medical tourism industry. Other regional drivers are rising disposable incomes, unmet medical needs, and gradual improvements in healthcare infrastructure. Key companies operating in the worldwide industry are DTR Medical; Cardinal Health Inc.; Hologic Inc.; Devicor Medical Products Inc,; and C.R. Bard Inc. Researchers from the University of Adelaide have developed a novel medical device that could lead to safer brain surgeries. It is a smart needle that helps spot blood vessels in the body. A miniature imaging probe placed inside a brain biopsy needle enables surgeons to see those blood vessels that are prone to risks. These needles on being inserted avoid causing fatal bleeds during the procedure. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog - https://hexaresearchinc.wordpress.com/ Healthcare 3D Printing Market Analysis, Size, Share, Growth and Forecast to 2020 | Hexa Research7/7/2017 The Global Healthcare 3D Printing Market can register a CAGR nearly 16% over the forecast period (2012 to 2020). The industry is fueled by an expanding global population and rapidly evolving technology. With the aid of additive processes, 3D printers help create digital files with three dimensional views. 3D printing technology is based on the concept of “prototyping” that helps in the development of real usable parts & products.
Besides healthcare, 3D printing is applied extensively in areas, such as aerospace, research, government, industrial machines, automotives, and defense among others. In medicine, 3D printing is used in critical cases, like hearing aids, jaw implants, prosthesis, and heart surgeries etc. It is increasingly being used in hip implants, dental crowns, knee implants, and orthotic footwear. A number of healthcare professionals are trying to incorporate 3D printing in surgeries, since it lowers the risks associated with anesthesia. Browse Details of Report@ https://www.hexaresearch.com/research-report/healthcare-3d-printing-industry The worldwide industry is segmented as per applications, technologies, raw materials, and regions. According to applications, the categories are surgical instruments, implants, bioengineering, and surgical guides. Due to frequent applications in skull replacement, medical implants held the highest market share in 2013. Different types of implants are orthopedic, crani-maxillofacial, and dental surgical. In digital dentistry, 3D printing provides finished dental prosthetics in metal. The process is accurate, cheap, and minimally invasive. According to technologies, the overall Healthcare 3D Printing Market is categorized into droplet deposition, photo-polymerization, laser beam melting, and electron beam melting. The droplet deposition segment generated highest revenues in 2013. It is sub-segmented into multiphase jet solidification, fused deposition modeling, and inkjet printing. Inkjet printing is widely applied in bio-printing, since it helps print living tissues. Bio-printing involves the use of bio-ink, a mixture of living cells. Bio-ink is a substance that can be printed into any desired shape. Raw materials that are employed in the healthcare 3D printing industry are ceramics, polymers, biological cells, and metals. Polymers dominated the overall market in 2013. Propelled by popularity, awareness, and technological advancements, this segment may continue dominating the market throughout the forecast period. Geographically, the worldwide Healthcare 3D Printing Market is divided into Asia Pacific, Europe, North America, and Rest of the World. North America is the leading regional market. Factors that fuel the region are well developed healthcare infrastructure, high R&D investments in 3D technologies, and surging healthcare spending. Owing to widespread adoption of 3D & 4D technologies and high healthcare expenditure, Asia Pacific may expand remarkably in the forthcoming years. Europe too, is expected to grow considerably during the same time period owing to surging demand for customized medical equipment. Prominent companies operating in the global healthcare 3D printing market are Youbionic, Rainbow Biosciences, Roche Pharmaceuticals, 3D Systems Corporation, and Bio-Rad Laboratories. Early this year, a research team in Korea, with the help of a 3D bio-printer developed a special myocardial therapeutic patch for ischemic heart disease. This patch generates new tissues & blood vessels when attached to the patient’s heart. The researchers tested the same by transplanting the 3D printed heart patch into the epicardium of diseased hearts of lab animals. After the implant, it was observed that the patch lowered the hardness of a few fibrotic areas that were damaged by insufficient blood supply. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog - https://hexaresearchinc.wordpress.com/ |
Archives
October 2023
|